Download Citation
Article Source:
IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study
Suppiah V,
Gaudieri S,
Armstrong NJ,
O'Connor KS,
Berg T,
et al.
(2011)
IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study.
PLOS Medicine 8(9): e1001092.
https://doi.org/10.1371/journal.pmed.1001092